Author

Douglas B. MacLean

Observed names: Doug B. MacLean, MacLean, Douglas B.

Observed institution: Xention (United Kingdom)

OpenAlex ID: A5111076464

Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high‐risk non–muscle‐invasive bladder cancer

2021 · Angela B. Smith, Jenney R. Lee, et al. · Cancer · 16

Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non–Muscle-Invasive Bladder Cancer

2025 · John L. Gore, Erika M. Wolff, et al. · Journal of Clinical Oncology · 14

Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer

2023 · John L. Gore, Erika M. Wolff, et al. · BMC Cancer · 7

Works count: 5

Citation count: 37

H-index: 3

I10-index: 2